Wilfactin

Wilfactin is a human-derived von Willebrand factor used to manage bleeding disorders. This intravenous treatment supports blood clotting in conditions like von Willebrand disease. A trusted option for patients requiring factor replacement therapy. Suitable for those seeking reliable clotting support.

Wilfactin is used to treat and prevent bleeding episodes in patients with von Willebrand disease, a condition that affects blood clotting. It provides the missing or dysfunctional von Willebrand factor needed for proper clotting. This medication is often prescribed for routine prophylaxis or on-demand treatment during surgical procedures. It may also be used in patients with hemophilia A who have developed inhibitors.

Wilfactin works by replacing the missing von Willebrand factor in the blood, helping to restore normal clotting function. Patients may notice reduced frequency or severity of bleeding episodes after administration. Some individuals report improved mobility and reduced anxiety related to bleeding risks. The effects typically last until the body naturally breaks down the administered factor.

Wilfactin should be stored properly and used only as directed by a healthcare professional. Patients with known allergies to human blood products should avoid this medication. Regular monitoring may be required to ensure the treatment remains effective. Always inform your doctor of any other medications or medical conditions before starting Wilfactin.

Wilfactin may interact with medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Combining it with other clotting factor products should be done under medical supervision. Alcohol and certain herbal supplements may also influence clotting function. Always discuss your full medication list with your healthcare provider.